Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska ...

Our Director of Research Dr Sheona Scales describes her four highlights from this year's Clinical Trials on Alzheimer's ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications.

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...

Lt. Gov. Dan Patrick aims to pass legislation to create a new state-funded institute aimed at finding treatments, and ...

Some are small; others, biological, and there are also medications already approved for another purpose that seek to help in ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

Premier Susan Holt says her government will launch a transparent scientific investigation by early next year into the mystery ...